AI-Designed Vaccine Is Tested for the First Time

Cambridge scientists report a major milestone: they have tested a vaccine that was designed using artificial intelligence for the first time. The researchers used AI to help select promising targets and propose vaccine components, aiming to make the design process faster and more precise than traditional methods. After the AI suggestions were turned into a real vaccine, the team carried out early testing to evaluate safety and to measure immune responses—how well the body recognizes and reacts to the vaccine. This matters because a vaccine must do more than look promising in theory; it must trigger the right kind of protection in real biological systems. The study is still an early phase, so it does not yet prove the vaccine will work for everyone. However, it shows that AI can move from computer models to lab-made products and then into human testing. Larger clinical trials will be needed before any wider use is possible.